 |
Minimal deposit $50 Exclusive promotion |
Our score |
0% commission |
Are you looking to buy Sarepta Therapeutics stocks? Chech our BAMagazine with an in-depth review, check prices, statistics and see if buying this stock is interesting right now. This article will help you buy NASDAQ:SRPT! and analyze the company to see if this stock might be an interesting option to invest in. We will enlighten you about Sarepta Therapeutics stocks and how to buy and use them. Click on the button to start reading the review right now or scroll down for real time statistics about this company.
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapy, and other genetic therapeutic modalities approaches for the treatment of rare diseases. The company offers EXONDYS 51 injection to treat duchenne muscular dystrophy (DMD) in patients who have a confirmed mutation of the DMD gene that is amenable to exon 51 skipping; and VYONDYS 53 for the treatment of DMD in patients who have a confirmed mutation of the DMD gene that is amenable to exon 53 skipping. It also developing Casimersen, a product candidate that uses phosphorodiamidate morpholino oligomer (PMO) chemistry and exon-skipping technology to skip exon 45 of the DMD gene; SRP-5051, a peptide conjugated PMO that binds exon 51 of dystrophin pre-mRNA; SRP-9001, a DMD micro-dystrophin gene therapy program; SRP-9003, a limb-girdle muscular dystrophies gene therapy program; and LYS-SAF 302 to treat mucopolysaccharidosis type IIIA. The company has collaboration agreements with F. Hoffman-La Roche Ltd; Nationwide Children’s Hospital; Lysogene; Duke University; Genethon; StrideBio; the United States Army Medical Research Institute of Infectious Diseases; the Department of Defense’s lead laboratory; the Dyno Therapeutics, Inc; and Personalis, Inc. It also has a research and option agreement with Codiak BioSciences, Inc. to design and develop engineered exosome therapeutics to deliver gene therapy, gene editing, and RNA technologies for neuromuscular diseases; and research collaboration with Genevant Sciences for lipid nanoparticle-based gene editing therapeutics. Sarepta Therapeutics, Inc. was founded in 1980 and is headquartered in Cambridge, Massachusetts.
Average volume
3.65 million shs
MARKET CAP
$7.50 billion
Stock exchange
NASDAQ
Buy this stock!
- Stephen Johnson
- September 10, 2021
- No Comments
How to buy Sarepta Therapeutics stocks?
Below is a quick guide on how to buy NASDAQ:SRPT stocks safe, fast and around the world in less than five minutes.
Step 1: Open an account with eToro – eToro is the best broker to buy Sarepta Therapeutics shares in the world as you won’t pay any commissions. To do this, visit the eToro website and open an account, it is 100% safe and they offer a huge amount of stocks.
Step 2: Upload your ID – As per KYC regulations eToro will ask you to upload a copy of your passport or driver’s license.
Step 3: Deposit Funds – Deposit some money into your newly created eToro account. You can choose between wire transfer, e-wallet or debit/credit card or Paypal.
Step 4: Buy Sarepta Therapeutics – Search for “”NASDAQ:SRPT”” and click on the “”Trade”” button. Enter the total amount of your investment (minimum $50) and confirm the order by clicking the “”Open Trade”” button. And that’s it: you have just bought Sarepta Therapeutics stocks with 0% commission!.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
Is Sarepta Therapeutics a buy right now?
24 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for Sarepta Therapeutics in the last twelve months. There are currently 1 sell rating, 8 hold ratings and 15 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should “buy” Sarepta Therapeutics stock.
What stocks does BAMagazine like better than Sarepta Therapeutics?
Wall Street analysts have given Sarepta Therapeutics a “Buy” rating, but there may be better short-term opportunities in the market. Some of BAMagazine’s past winning trading ideas have resulted in 5-15% weekly gains. BAMagazine just released five new trading ideas, but Sarepta Therapeutics wasn’t one of them. BAMagazine thinks five stocks may be even better buys in the how to buy stocks guide.
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
2 |  | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
3 |  | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
How to buy Sarepta Therapeutics stocks step by step guide
It can be difficult to navigate through all the outdated and incorrect information related to purchasing NASDAQ:SRPT stocks. We believe that stocks should be accessible for all, which is why we’ve created this handy guide on where to buy Sarepta Therapeutics stocks with a step by step approach.
Step 1: Open an Account with a Broker
You’ll need to register with a broker, in these times you can’t go without once and it’s crucial to use a regulated broker that’s allowed to operate there, otherwise, you risk losing funds. eToro is one such broker, and one of the best brokers to buy Sarepta Therapeutics stocks with 0% comission, to sign up just click on open account in the following table or compare other options.
Step 2: Verify your Account
Because eToro is a regulated platform, you’ll need to complete the KYC process, this is standard practice and only takes a couple of minutes. You’ll need to provide a photo ID (passport, driving licence) and proof of address (utility bill, bank statement).
Step 3: Fund your eToro Account
Once you’ve signed up and verified your account, you’ll need to deposit funds. eToro accepts credit/debit cards, bank transfers, and also e-wallets. So whatever your preference there will be something for you.
Step 4: Search for Sarepta Therapeutics stocks
Now that you’ve funded your eToro account, just type “NASDAQ:SRPT stocks” into the search bar at the top of the screen and press “trade”.
Step 5: Buy NASDAQ:SRPT
All that’s left is to buy some NASDAQ:SRPT stock. Simply enter the amount you want to purchase and hit the “buy” button. The amount you bought will be automatically credited to your account where you can monitor its performance.
How And Where To Buy Stocks Conclusion
All in all, NASDAQ:SRPT is an incredibly interesting company that has the potential to solve some major issues in the business space. After reading this guide you should know how to buy this investment using the best broker or platform. We recommend eToro to anyone looking for a regulated, easy-to-use, fully-featured broker to buy Sarepta Therapeutics stocks. As with any broker or online platform, it’s crucial you set up 2FA when using their tools as it ensures your funds are completely safe.
When is Sarepta Therapeutics’ next earnings date?
Sarepta Therapeutics is scheduled to release its next quarterly earnings announcement on Wednesday, February 24th 2021.
View our earnings forecast for Sarepta Therapeutics.
How were Sarepta Therapeutics’ earnings last quarter?
Sarepta Therapeutics, Inc. (NASDAQ:SRPT) released its earnings results on Thursday, November, 5th. The biotechnology company reported ($2.50) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($1.89) by $0.61. The biotechnology company earned $143.92 million during the quarter, compared to analyst estimates of $133.69 million. Sarepta Therapeutics had a negative net margin of 121.30% and a negative trailing twelve-month return on equity of 61.62%. The business’s revenue for the quarter was up 45.3% on a year-over-year basis. During the same quarter in the previous year, the business earned ($1.14) earnings per share.
View Sarepta Therapeutics’ earnings history.
How has Sarepta Therapeutics’ stock been impacted by Coronavirus?
Sarepta Therapeutics’ stock was trading at $102.8150 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization (WHO). Since then, SRPT shares have decreased by 6.9% and is now trading at $95.73.
What price target have analysts set for SRPT?
24 analysts have issued twelve-month price objectives for Sarepta Therapeutics’ shares. Their forecasts range from $73.00 to $240.00. On average, they anticipate Sarepta Therapeutics’ share price to reach $161.96 in the next year. This suggests a possible upside of 69.2% from the stock’s current price.
View analysts’ price targets for Sarepta Therapeutics or view top-rated stocks among Wall Street analysts.
Where to Buy Sarepta Therapeutics Stocks Broker Reviews
Launched in 2006, eToro is, in our opinion, without a doubt the best broker for buying NASDAQ:SRPT stocks in the world. The onboarding process is simple, it’s designed to make sure even those new to the stock market are ready to start investing the shortest amount of time possible. As a regulated platform you gain several benefits, most importantly, you know they’re not going to run off with your hard-earned money./
- eToro takes pride in keeping their customers safe, they follow strict data protection rules to keep access to sensitive information to a minimum. Any of the information you provide eToro is even protected by SSL encryption, this ensures that even if someone were to gain access to the servers all your data remains safe.
Over 95% of client funds are kept offline, in cold storage, which is crucial for any broker that manages your assets. Regardless of how secure a platform is meant to be, we recommend using 2FA to add an additional layer of security to your account.
Excellent for both new and experienced traders
eToro offers users a range of features to start investing as quickly as possible. They have a relatively unique feature called copy trading, which lets you earn a passive income by mirroring experienced traders, this allows you to start earning profit quickly, and gives you a better understanding of the strategies used by professionals. Additionally, eToro allows users to invest in managed portfolios, a managed portfolio being a variety of similar assets grouped together, allowing you to diversify your account, reducing any potential risk. For those with previous trading experience, you can invest in markets outside of stocks, as eToro allows users to trade ETFs, commodities, crypto and indices. If you already invest outside of the stock market space this can be very useful, as it allows you to manage all your investments in just one place.
Are investors shorting Sarepta Therapeutics?
Sarepta Therapeutics saw a increase in short interest in January. As of January 15th, there was short interest totaling 8,100,000 shares, an increase of 14.6% from the December 31st total of 7,070,000 shares. Based on an average trading volume of 1,780,000 shares, the days-to-cover ratio is presently 4.6 days.
View Sarepta Therapeutics’ Short Interest.
Who are Sarepta Therapeutics’ key executives?
Sarepta Therapeutics’ management team includes the following people:
Mr. Douglas S. Ingram, Pres, CEO & Director (Age 58, Pay $1.39M)
Mr. William F. Ciambrone, Exec. VP of Technical Operations (Age 57, Pay $438.01k)
Mr. David Tyronne Howton Jr., Consultant (Age 49, Pay $731.8k)
Dr. Gilmore O’Neill M.D., Exec. VP of R&D and Chief Medical Officer (Age 56, Pay $933.33k)
Mr. Ian Michael Estepan, Exec. VP, Principal Financial and Accounting Officer & CFO (Age 45)
Dr. Louise Rodino-Klapac Ph.D., Exec. VP & Chief Scientific Officer
Mr. Ryan E. Brown, VP, Global Chief Compliance Officer, Regulatory Counsel & Interim Gen. Counsel
Dr. Diane L. Berry, Sr. VP of Global Health Policy and Gov. & Patient Affairs
Ms. Joan Nickerson M.B.A., Sr. VP of HR
Mr. Dallan Murray, Sr. VP & Chief Commercial Officer
Compliance
CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 68% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work, and whether you can afford to take the high risk of losing your money.
What is Douglas S. Ingram’s approval rating as Sarepta Therapeutics’ CEO?
15 employees have rated Sarepta Therapeutics CEO Douglas S. Ingram on Glassdoor.com. Douglas S. Ingram has an approval rating of 95% among Sarepta Therapeutics’ employees. This puts Douglas S. Ingram in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.
Who are some of Sarepta Therapeutics’ key competitors?
Some companies that are related to Sarepta Therapeutics include Shiseido (SSDOY), Takeda Pharmaceutical (TKPYY), Genmab A/S (GMAB), Genmab A/S (GNMSF), MERCK Kommanditgesellschaft auf Aktien (MKGAF), CureVac (CVAC), UCB (UCBJF), Catalent (CTLT), Alnylam Pharmaceuticals (ALNY), Horizon Therapeutics Public (HZNP), Royalty Pharma (RPRX), BioMarin Pharmaceutical (BMRN), Ono Pharmaceutical (OPHLF), Elanco Animal Health (ELAN) and Teva Pharmaceutical Industries (TEVA).
View all of SRPT’s competitors.
What other stocks do shareholders of Sarepta Therapeutics own?
Based on aggregate information from BAMagazine watchlists, some companies that other Sarepta Therapeutics investors own include Intercept Pharmaceuticals (ICPT), NVIDIA (NVDA), Micron Technology (MU), Advanced Micro Devices (AMD), Gilead Sciences (GILD), Alibaba Group (BABA), Netflix (NFLX), Tesla (TSLA), AbbVie (ABBV) and The Walt Disney (DIS).
What is Sarepta Therapeutics’ stock symbol?
Sarepta Therapeutics trades on the NASDAQ under the ticker symbol “SRPT.”
1 | | Minimal deposit $50 Exclusive promotion | Our score 10 ★★★★★ | 0% commission |
Who are Sarepta Therapeutics’ major shareholders?
Sarepta Therapeutics’ stock is owned by many different institutional and retail investors. Top institutional investors include First Trust Advisors LP (0.68%), Sumitomo Mitsui Trust Holdings Inc. (0.42%), Swiss National Bank (0.36%), California Public Employees Retirement System (0.23%), Candriam Luxembourg S.C.A. (0.21%) and C WorldWide Group Holding A S (0.15%). Company insiders that own Sarepta Therapeutics stock include Alexander Cumbo, David T Howton, Douglas S Ingram, Hans Lennart Rudolf Wigzell, Joseph Bratica, M Kathleen Behrens, Michael W Bonney, Richard Barry and Sandesh Mahatme.
View institutional ownership trends for Sarepta Therapeutics.
Which institutional investors are selling Sarepta Therapeutics stock?
SRPT stock was sold by a variety of institutional investors in the last quarter, including Los Angeles Capital Management LLC, First Trust Advisors LP, C WorldWide Group Holding A S, Candriam Luxembourg S.C.A., Swiss National Bank, State of Wisconsin Investment Board, Pinnacle Associates Ltd., and Strs Ohio. Company insiders that have sold Sarepta Therapeutics company stock in the last year include David T Howton, Hans Lennart Rudolf Wigzell, Joseph Bratica, and Richard Barry.
View insider buying and selling activity for Sarepta Therapeutics or view top insider-selling stocks.
Which institutional investors are buying Sarepta Therapeutics stock?
SRPT stock was purchased by a variety of institutional investors in the last quarter, including TCW Group Inc., Lehman & Derafelo Financial Resources LLC, CWM LLC, DNB Asset Management AS, Zurcher Kantonalbank Zurich Cantonalbank, California Public Employees Retirement System, WBI Investments, and Nia Impact Advisors LLC. Company insiders that have bought Sarepta Therapeutics stock in the last two years include Douglas S Ingram, M Kathleen Behrens, Michael W Bonney, and Richard Barry.
View insider buying and selling activity for Sarepta Therapeutics or or view top insider-buying stocks.
How do I buy shares of Sarepta Therapeutics?
Shares of SRPT can be purchased through any online brokerage account. Popular online brokerages with access to the stock market include Interactive Brokers Review, eToro Review, DEGiro Review, AvaTrade Review, IG Markets Review, IC Markets Review, CMC Markets Review, Admiral Markets Review and many more. Read one of the reviews to find out everything about the broker and start buying stocks now.
What is Sarepta Therapeutics’ stock price today?
One share of SRPT stock can currently be purchased for approximately $95.73.
How much money does Sarepta Therapeutics make?
Sarepta Therapeutics has a market capitalization of $7.55 billion and generates $380.83 million in revenue each year. The biotechnology company earns $-715,080,000.00 in net income (profit) each year or ($9.71) on an earnings per share basis.
More information
At BAMagazine.com we want to make sure that you have all the most relevant information about buying stocks. We bring you the best guides about the stock market with personal reviews, background information, platform reviews, how to’s and more. Want to get other information? Then check out the OTC stocks, NASDAQ stocks, NYSE stocks, LON stocks, FRA stocks, ETR stocks, EPA stocks, TSX stocks or Amex stocks. Looking for more detailed info like 5g stocks, biotech stocks, gold stocks and other information out of our reportlab.
Frequently asked questions
How can you buy Sarepta Therapeutics stock on the internet?
You can easily buy Sarepta Therapeutics stocks with one of the well known regulated brokers on the internet. You can open an account within 5 minutes, make deposits with countless payment providers and trade with professional tools on their platform. At the moment, our visitors rate eToro as the most popular choice.
Another option is using a regulated broker like IC Markets or Interactive Brokers. You can an account with these brokers and start buying or trading NASDAQ:SRPT stocks in a safe and complete environment to trade in.
Where to buy Sarepta Therapeutics stock?
You will first want to find a licensed broker that supports NASDAQ:SRPT stock. One of our favourite brokers, eToro for example, allows you to make investments into this asset from just $25 and only charges you the spread. Another option is using a regulated broker like DEGIRO or Interactive Brokers. You can open an account with these brokers and start buying or trading NASDAQ:SRPT stocks in a safe and complete environment.
Is NASDAQ:SRPT stock a good investment?
As with any other asset, there is an element of risk associated with buying NASDAQ:SRPT stocks. Therefore, you will want to study the market and make a decision based on your financial standing and the risk you are willing to take.
Is Sarepta Therapeutics stock safe to invest in?
All stocks are volatile, or affected by market circumstances. The case with NASDAQ:SRPT is no different, with its price fluctuating dramatically within short periods. As such, if the market goes against you, then you will end up facing a loss. We advice you to do research first before investing in Sarepta Therapeutics stock.
How do you trade Sarepta Therapeutics stocks?
You can trade stocks by first opening an account with a regulated platform and making a deposit in US dollars, EUROs or other currency. Next, search for Sarepta Therapeutics stock and choose from a buy or sell order – depending on whether you think the stock asset will rise or fall in value. If you speculated on NASDAQ:SRPT stocks correctly, you will have made a profit. The size of your trading profit will ultimately be determined by your stake and at what percentage your position grew.
How to sell Sarepta Therapeutics stock?
To sell your NASDAQ:SRPT stocks investment, you can sign in to your broker account and cash out directly from within your portfolio. If you have stored the stocks elsewhere, you will first have to transfer them to a third-party provider or broker to cash out.
What is the best Sarepta Therapeutics stock trading platform?
eToro, is a top-rated platform for beginners, albeit, it charges significantly lower fees. For example, there are no fees to deposit with a debit/credit card and you only need to cover the spread when trading NASDAQ:SRPT stock.
Share this information
Share on facebook
Facebook
Share on twitter
Twitter
Stephen Johnson
Stephen knows a lot about financial products and in particular has a great passion for the stock markets and its participants. We hope that the information provided will help you. Something not quite clear? Please leave your questions or comments at the bottom of the page.
| Our score ★★★★★ | |
| Our score ★★★★★ | |
| Our score ★★★★★ |
Newsletter
Recent News
Table of Contents
| |
Our score |
0% commission |
Other stocks
| Symbol | Name | Ticker | Score | More information | Buy this stock |
|---|---|---|---|---|---|
 | Nutanix | NASDAQ:NTNX | ★★★★★ | Buy Nutanix Stock guide | |
 | E*TRADE Financial | NASDAQ:ETFC | ★★★★★ | Buy E*TRADE Financial Stock guide | |
 | Netflix | NASDAQ:NFLX | ★★★★★ | Buy Netflix Stock guide | |
 | Panera Bread Company | NASDAQ:PNRA | ★★★★★ | Buy Panera Bread Company Stock guide | |
 | ASML | NASDAQ:ASML | ★★★★★ | Buy ASML Stock guide | |
 | Bed Bath & Beyond | NASDAQ:BBBY | ★★★★★ | Buy Bed Bath & Beyond Stock guide | |
 | Viavi Solutions | NASDAQ:VIAV | ★★★★★ | Buy Viavi Solutions Stock guide | |
 | Fossil Group | NASDAQ:FOSL | ★★★★★ | Buy Fossil Group Stock guide | |
 | SanDisk | NASDAQ:SNDK | ★★★★★ | Buy SanDisk Stock guide | |
 | Lam Research | NASDAQ:LRCX | ★★★★★ | Buy Lam Research Stock guide | |
 | The Hain Celestial Group | NASDAQ:HAIN | ★★★★★ | Buy The Hain Celestial Group Stock guide | |
 | Sirius XM | NASDAQ:SIRI | ★★★★★ | Buy Sirius XM Stock guide | |
 | Semtech | NASDAQ:SMTC | ★★★★★ | Buy Semtech Stock guide | |
 | Silicon Laboratories | NASDAQ:SLAB | ★★★★★ | Buy Silicon Laboratories Stock guide | |
 | Infinera | NASDAQ:INFN | ★★★★★ | Buy Infinera Stock guide | |
 | FOX | NASDAQ:FOXA | ★★★★★ | Buy FOX Stock guide | |
 | Incyte | NASDAQ:INCY | ★★★★★ | Buy Incyte Stock guide | |
 | eBay | NASDAQ:EBAY | ★★★★★ | Buy eBay Stock guide | |
 | Intel | NASDAQ:INTC | ★★★★★ | Buy Intel Stock guide | |
 | MercadoLibre | NASDAQ:MELI | ★★★★★ | Buy MercadoLibre Stock guide | |
 | JD.com | NASDAQ:JD | ★★★★★ | Buy JD.com Stock guide | |
 | Exact Sciences | NASDAQ:EXAS | ★★★★★ | Buy Exact Sciences Stock guide | |
 | Discovery | NASDAQ:DISCA | ★★★★★ | Buy Discovery Stock guide | |
 | Alexion Pharmaceuticals | NASDAQ:ALXN | ★★★★★ | Buy Alexion Pharmaceuticals Stock guide | |
 | bluebird bio | NASDAQ:BLUE | ★★★★★ | Buy bluebird bio Stock guide | |
 | Athenahealth | NASDAQ:ATHN | ★★★★★ | Buy Athenahealth Stock guide | |
 | The Wendy’s | NASDAQ:WEN | ★★★★★ | Buy The Wendy’s Stock guide | |
 | Illumina | NASDAQ:ILMN | ★★★★★ | Buy Illumina Stock guide | |
 | Zynga | NASDAQ:ZNGA | ★★★★★ | Buy Zynga Stock guide | |
 | Walgreens Boots Alliance | NASDAQ:WBA | ★★★★★ | Buy Walgreens Boots Alliance Stock guide | |
 | Starbucks | NASDAQ:SBUX | ★★★★★ | Buy Starbucks Stock guide | |
 | Allscripts Healthcare Solutions | NASDAQ:MDRX | ★★★★★ | Buy Allscripts Healthcare Solutions Stock guide | |
 | Synaptics | NASDAQ:SYNA | ★★★★★ | Buy Synaptics Stock guide | |
 | Match Group | NASDAQ:MTCH | ★★★★★ | Buy Match Group Stock guide | |
 | The Kraft Heinz | NASDAQ:KHC | ★★★★★ | Buy The Kraft Heinz Stock guide | |
 | G III Apparel Group | NASDAQ:GIII | ★★★★★ | Buy G III Apparel Group Stock guide | |
 | OasPetroleum | NASDAQ:OAS | ★★★★★ | Buy OasPetroleum Stock guide | |
 | PepsiCo | NASDAQ:PEP | ★★★★★ | Buy PepsiCo Stock guide | |
 | Baidu | NASDAQ:BIDU | ★★★★★ | Buy Baidu Stock guide | |
 | BJ’s Restaurants | NASDAQ:BJRI | ★★★★★ | Buy BJ’s Restaurants Stock guide | |
 | Activision Blizzard | NASDAQ:ATVI | ★★★★★ | Buy Activision Blizzard Stock guide | |
 | Advanced Micro Devices | NASDAQ:AMD | ★★★★★ | Buy Advanced Micro Devices Stock guide | |
 | Cree | NASDAQ:CREE | ★★★★★ | Buy Cree Stock guide | |
 | Dollar Tree | NASDAQ:DLTR | ★★★★★ | Buy Dollar Tree Stock guide | |
 | T Mobile US | NASDAQ:TMUS | ★★★★★ | Buy T Mobile US Stock guide | |
 | The Carlyle Group | NASDAQ:CG | ★★★★★ | Buy The Carlyle Group Stock guide | |
 | DISH Network | NASDAQ:DISH | ★★★★★ | Buy DISH Network Stock guide | |
 | Xilinx | NASDAQ:XLNX | ★★★★★ | Buy Xilinx Stock guide | |
 | Sonic | NASDAQ:SONC | ★★★★★ | Buy Sonic Stock guide | |
 | American Electric Power | NASDAQ:AEP | ★★★★★ | Buy American Electric Power Stock guide | |
 | Seagate Technology | NASDAQ:STX | ★★★★★ | Buy Seagate Technology Stock guide | |
 | PTC | NASDAQ:PTC | ★★★★★ | Buy PTC Stock guide | |
 | CyrusOne | NASDAQ:CONE | ★★★★★ | Buy CyrusOne Stock guide | |
 | Hologic | NASDAQ:HOLX | ★★★★★ | Buy Hologic Stock guide | |
 | Microchip Technology | NASDAQ:MCHP | ★★★★★ | Buy Microchip Technology Stock guide | |
 | Huntington Bancshares | NASDAQ:HBAN | ★★★★★ | Buy Huntington Bancshares Stock guide | |
 | Five Below | NASDAQ:FIVE | ★★★★★ | Buy Five Below Stock guide | |
 | Ambarella | NASDAQ:AMBA | ★★★★★ | Buy Ambarella Stock guide | |
 | NetEase | NASDAQ:NTES | ★★★★★ | Buy NetEase Stock guide | |
 | Expedia Group | NASDAQ:EXPE | ★★★★★ | Buy Expedia Group Stock guide | |
 | Columbia Sportswear | NASDAQ:COLM | ★★★★★ | Buy Columbia Sportswear Stock guide | |
 | Cerner | NASDAQ:CERN | ★★★★★ | Buy Cerner Stock guide | |
 | TiVo | NASDAQ:TIVO | ★★★★★ | Buy TiVo Stock guide | |
 | Biogen | NASDAQ:BIIB | ★★★★★ | Buy Biogen Stock guide | |
 | Symantec | NASDAQ:SYMC | ★★★★★ | Buy Symantec Stock guide | |
 | Marriott International | NASDAQ:MAR | ★★★★★ | Buy Marriott International Stock guide | |
 | Sprouts Farmers Market | NASDAQ:SFM | ★★★★★ | Buy Sprouts Farmers Market Stock guide | |
 | PDC Energy | NASDAQ:PDCE | ★★★★★ | Buy PDC Energy Stock guide | |
 | Horizon Therapeutics Public | NASDAQ:HZNP | ★★★★★ | Buy Horizon Therapeutics Public Stock guide | |
 | Applied Materials | NASDAQ:AMAT | ★★★★★ | Buy Applied Materials Stock guide | |
 | NXP Semiconductors | NASDAQ:NXPI | ★★★★★ | Buy NXP Semiconductors Stock guide | |
 | C.H. Robinson Worldwide | NASDAQ:CHRW | ★★★★★ | Buy C.H. Robinson Worldwide Stock guide | |
 | Ulta Beauty | NASDAQ:ULTA | ★★★★★ | Buy Ulta Beauty Stock guide | |
 | Cintas | NASDAQ:CTAS | ★★★★★ | Buy Cintas Stock guide | |
 | Steel Dynamics | NASDAQ:STLD | ★★★★★ | Buy Steel Dynamics Stock guide | |
 | Intuit | NASDAQ:INTU | ★★★★★ | Buy Intuit Stock guide | |
 | Groupon | NASDAQ:GRPN | ★★★★★ | Buy Groupon Stock guide | |
 | Aerie Pharmaceuticals | NASDAQ:AERI | ★★★★★ | Buy Aerie Pharmaceuticals Stock guide | |
 | Urban Outfitters | NASDAQ:URBN | ★★★★★ | Buy Urban Outfitters Stock guide | |
 | Zions Bancorporation | NASDAQ:ZION | ★★★★★ | Buy Zions Bancorporation Stock guide | |
 | Zumiez | NASDAQ:ZUMZ | ★★★★★ | Buy Zumiez Stock guide | |
 | Express Scripts | NASDAQ:ESRX | ★★★★★ | Buy Express Scripts Stock guide | |
 | Intuitive Surgical | NASDAQ:ISRG | ★★★★★ | Buy Intuitive Surgical Stock guide | |
 | Intercept Pharmaceuticals | NASDAQ:ICPT | ★★★★★ | Buy Intercept Pharmaceuticals Stock guide | |
 | Qualys | NASDAQ:QLYS | ★★★★★ | Buy Qualys Stock guide | |
| Sarepta Therapeutics | NASDAQ:SRPT | ★★★★★ | Buy Sarepta Therapeutics Stock guide | |
 | KLA | NASDAQ:KLAC | ★★★★★ | Buy KLA Stock guide | |
 | Kinder Morgan | NYSE:KMI | ★★★★★ | Buy Kinder Morgan Stock guide | |
 | Fiserv | NASDAQ:FISV | ★★★★★ | Buy Fiserv Stock guide | |
 | Shire | NASDAQ:SHPG | ★★★★★ | Buy Shire Stock guide | |
 | NuVasive | NASDAQ:NUVA | ★★★★★ | Buy NuVasive Stock guide | |
 | Cisco Systems | NASDAQ:CSCO | ★★★★★ | Buy Cisco Systems Stock guide | |
 | Methanex | NASDAQ:MEOH | ★★★★★ | Buy Methanex Stock guide | |
 | Whole Foods | NASDAQ:WFM | ★★★★★ | Buy Whole Foods Stock guide | |
 | Cornerstone OnDemand | NASDAQ:CSOD | ★★★★★ | Buy Cornerstone OnDemand Stock guide | |
 | NASDAQ:FB | ★★★★★ | Buy Facebook Stock guide | ||
 | Cavium | NASDAQ:CAVM | ★★★★★ | Buy Cavium Stock guide | |
 | American Airlines Group | NASDAQ:AAL | ★★★★★ | Buy American Airlines Group Stock guide | |
 | Check Point Software Technologies | NASDAQ:CHKP | ★★★★★ | Buy Check Point Software Technologies Stock guide | |
 | Signature Bank | NASDAQ:SBNY | ★★★★★ | Buy Signature Bank Stock guide | |
 | ARM Holdings | NASDAQ:ARMH | ★★★★★ | Buy ARM Holdings Stock guide | |
 | Cirrus Logic | NASDAQ:CRUS | ★★★★★ | Buy Cirrus Logic Stock guide | |
 | The Finish Line | NASDAQ:FINL | ★★★★★ | Buy The Finish Line Stock guide | |
 | LM Ericsson | NASDAQ:ERIC | ★★★★★ | Buy LM Ericsson Stock guide | |
 | Hasbro | NASDAQ:HAS | ★★★★★ | Buy Hasbro Stock guide | |
 | F5 Networks | NASDAQ:FFIV | ★★★★★ | Buy F5 Networks Stock guide | |
 | Texas Roadhouse | NASDAQ:TXRH | ★★★★★ | Buy Texas Roadhouse Stock guide | |
 | Monster Beverage | NASDAQ:MNST | ★★★★★ | Buy Monster Beverage Stock guide | |
 | The Children’s Place | NASDAQ:PLCE | ★★★★★ | Buy The Children’s Place Stock guide | |
 | Penn National Gaming | NASDAQ:PENN | ★★★★★ | Buy Penn National Gaming Stock guide | |
 | QUALCOMM | NASDAQ:QCOM | ★★★★★ | Buy QUALCOMM Stock guide | |
 | Alphabet | NASDAQ:GOOGL | ★★★★★ | Buy Alphabet Stock guide | |
 | CSX | NASDAQ:CSX | ★★★★★ | Buy CSX Stock guide | |
 | Ultragenyx Pharmaceutical | NASDAQ:RARE | ★★★★★ | Buy Ultragenyx Pharmaceutical Stock guide | |
 | Vertex Pharmaceuticals | NASDAQ:VRTX | ★★★★★ | Buy Vertex Pharmaceuticals Stock guide | |
 | O’Reilly Automotive | NASDAQ:ORLY | ★★★★★ | Buy O’Reilly Automotive Stock guide | |
 | Amazon | NASDAQ:AMZN | ★★★★★ | Buy Amazon Stock guide | |
 | Workday | NASDAQ:WDAY | ★★★★★ | Buy Workday Stock guide | |
 | ACADIA Pharmaceuticals | NASDAQ:ACAD | ★★★★★ | Buy ACADIA Pharmaceuticals Stock guide | |
 | Apache | NASDAQ:APA | ★★★★★ | Buy Apache Stock guide | |
 | Newell Brands | NASDAQ:NWL | ★★★★★ | Buy Newell Brands Stock guide | |
 | Comcast | NASDAQ:CMCSA | ★★★★★ | Buy Comcast Stock guide | |
 | SolarEdge Technologies | NASDAQ:SEDG | ★★★★★ | Buy SolarEdge Technologies Stock guide | |
 | Nuance Communications | NASDAQ:NUAN | ★★★★★ | Buy Nuance Communications Stock guide | |
 | Tesla | NASDAQ:TSLA | ★★★★★ | Buy Tesla Stock guide | |
 | Charter Communications | NASDAQ:CHTR | ★★★★★ | Buy Charter Communications Stock guide | |
 | CME Group | NASDAQ:CME | ★★★★★ | Buy CME Group Stock guide | |
 | Fifth Third Bancorp | NASDAQ:FITB | ★★★★★ | Buy Fifth Third Bancorp Stock guide | |
 | Maxim Integrated Products | NASDAQ:MXIM | ★★★★★ | Buy Maxim Integrated Products Stock guide | |
 | Akamai Technologies | NASDAQ:AKAM | ★★★★★ | Buy Akamai Technologies Stock guide | |
 | Insulet | NASDAQ:PODD | ★★★★★ | Buy Insulet Stock guide | |
 | Integra LifeSciences | NASDAQ:IART | ★★★★★ | Buy Integra LifeSciences Stock guide | |
 | Alnylam Pharmaceuticals | NASDAQ:ALNY | ★★★★★ | Buy Alnylam Pharmaceuticals Stock guide | |
 | Cypress Semiconductor | NASDAQ:CY | ★★★★★ | Buy Cypress Semiconductor Stock guide | |
 | Buffalo Wild Wings | NASDAQ:BWLD | ★★★★★ | Buy Buffalo Wild Wings Stock guide | |
 | Myriad Genetics | NASDAQ:MYGN | ★★★★★ | Buy Myriad Genetics Stock guide | |
 | Sage Therapeutics | NASDAQ:SAGE | ★★★★★ | Buy Sage Therapeutics Stock guide | |
 | BioMarin Pharmaceutical | NASDAQ:BMRN | ★★★★★ | Buy BioMarin Pharmaceutical Stock guide | |
 | Hibbett Sports | NASDAQ:HIBB | ★★★★★ | Buy Hibbett Sports Stock guide | |
 | Texas Capital Bancshares | NASDAQ:TCBI | ★★★★★ | Buy Texas Capital Bancshares Stock guide | |
 | AMC Networks | NASDAQ:AMCX | ★★★★★ | Buy AMC Networks Stock guide | |
 | Wright Medical Group | NASDAQ:WMGI | ★★★★★ | Buy Wright Medical Group Stock guide | |
 | Host Hotels & Resorts | NASDAQ:HST | ★★★★★ | Buy Host Hotels & Resorts Stock guide | |
 | DexCom | NASDAQ:DXCM | ★★★★★ | Buy DexCom Stock guide | |
 | ON Semiconductor | NASDAQ:ON | ★★★★★ | Buy ON Semiconductor Stock guide | |
 | Electronic Arts | NASDAQ:EA | ★★★★★ | Buy Electronic Arts Stock guide | |
 | Texas Instruments | NASDAQ:TXN | ★★★★★ | Buy Texas Instruments Stock guide | |
 | PACCAR | NASDAQ:PCAR | ★★★★★ | Buy PACCAR Stock guide | |
 | The Cheesecake Factory | NASDAQ:CAKE | ★★★★★ | Buy The Cheesecake Factory Stock guide | |
 | AstraZeneca | NASDAQ:AZN | ★★★★★ | Buy AstraZeneca Stock guide | |
 | Exelon | NASDAQ:EXC | ★★★★★ | Buy Exelon Stock guide | |
 | Stratasys | NASDAQ:SSYS | ★★★★★ | Buy Stratasys Stock guide | |
 | Apple | NASDAQ:AAPL | ★★★★★ | Buy Apple Stock guide | |
 | Pan American Silver | NASDAQ:PAAS | ★★★★★ | Buy Pan American Silver Stock guide | |
 | Allegiant Travel | NASDAQ:ALGT | ★★★★★ | Buy Allegiant Travel Stock guide | |
 | Viacom | NASDAQ:VIAB | ★★★★★ | Buy Viacom Stock guide | |
 | Steven Madden | NASDAQ:SHOO | ★★★★★ | Buy Steven Madden Stock guide | |
 | Medivation | NASDAQ:MDVN | ★★★★★ | Buy Medivation Stock guide | |
 | NVIDIA | NASDAQ:NVDA | ★★★★★ | Buy NVIDIA Stock guide | |
 | PayPal | NASDAQ:PYPL | ★★★★★ | Buy PayPal Stock guide | |
 | Pacira BioSciences | NASDAQ:PCRX | ★★★★★ | Buy Pacira BioSciences Stock guide | |
 | Booking | NASDAQ:BKNG | ★★★★★ | Buy Booking Stock guide | |
 | Citrix Systems | NASDAQ:CTXS | ★★★★★ | Buy Citrix Systems Stock guide | |
 | Nasdaq | NASDAQ:NDAQ | ★★★★★ | Buy Nasdaq Stock guide | |
 | Mattel | NASDAQ:MAT | ★★★★★ | Buy Mattel Stock guide | |
 | Mylan | NASDAQ:MYL | ★★★★★ | Buy Mylan Stock guide | |
 | Northern Trust | NASDAQ:NTRS | ★★★★★ | Buy Northern Trust Stock guide | |
 | FireEye | NASDAQ:FEYE | ★★★★★ | Buy FireEye Stock guide | |
 | IonPharmaceuticals | NASDAQ:IONS | ★★★★★ | Buy IonPharmaceuticals Stock guide | |
 | GoPro | NASDAQ:GPRO | ★★★★★ | Buy GoPro Stock guide | |
 | Royal Gold | NASDAQ:RGLD | ★★★★★ | Buy Royal Gold Stock guide | |
 | Mondelez International | NASDAQ:MDLZ | ★★★★★ | Buy Mondelez International Stock guide | |
 | TD Ameritrade | NASDAQ:AMTD | ★★★★★ | Buy TD Ameritrade Stock guide | |
 | Proofpoint | NASDAQ:PFPT | ★★★★★ | Buy Proofpoint Stock guide | |
 | Gulfport Energy | NASDAQ:GPOR | ★★★★★ | Buy Gulfport Energy Stock guide | |
 | Skyworks Solutions | NASDAQ:SWKS | ★★★★★ | Buy Skyworks Solutions Stock guide | |
 | Jazz Pharmaceuticals | NASDAQ:JAZZ | ★★★★★ | Buy Jazz Pharmaceuticals Stock guide | |
 | Analog Devices | NASDAQ:ADI | ★★★★★ | Buy Analog Devices Stock guide | |
 | Broadcom | NASDAQ:BRCM | ★★★★★ | Buy Broadcom Stock guide | |
 | TCF Financial | NASDAQ:TCF | ★★★★★ | Buy TCF Financial Stock guide | |
 | Wix.com | NASDAQ:WIX | ★★★★★ | Buy Wix.com Stock guide | |
 | Amarin | NASDAQ:AMRN | ★★★★★ | Buy Amarin Stock guide | |
 | Equinix | NASDAQ:EQIX | ★★★★★ | Buy Equinix Stock guide | |
 | Costco | NASDAQ:COST | ★★★★★ | Buy Costco Stock guide | |
 | First Solar | NASDAQ:FSLR | ★★★★★ | Buy First Solar Stock guide | |
 | Micron Technology | NASDAQ:MU | ★★★★★ | Buy Micron Technology Stock guide | |
 | Dunkin Brands Group | NASDAQ:DNKN | ★★★★★ | Buy Dunkin Brands Group Stock guide | |
 | Take Two Interactive | NASDAQ:TTWO | ★★★★★ | Buy Take Two Interactive Stock guide | |
 | Align Technology | NASDAQ:ALGN | ★★★★★ | Buy Align Technology Stock guide | |
 | Ctrip.Com International | NASDAQ:CTRP | ★★★★★ | Buy Ctrip.Com International Stock guide | |
 | Imperva | NASDAQ:IMPV | ★★★★★ | Buy Imperva Stock guide | |
 | T. Rowe Price Group | NASDAQ:TROW | ★★★★★ | Buy T. Rowe Price Group Stock guide | |
 | ANGI Homeservices | NASDAQ:ANGI | ★★★★★ | Buy ANGI Homeservices Stock guide | |
 | Adobe | NASDAQ:ADBE | ★★★★★ | Buy Adobe Stock guide | |
 | Neurocrine Biosciences | NASDAQ:NBIX | ★★★★★ | Buy Neurocrine Biosciences Stock guide | |
 | Western Digital | NASDAQ:WDC | ★★★★★ | Buy Western Digital Stock guide | |
 | Seagen | NASDAQ:SGEN | ★★★★★ | Buy Seagen Stock guide | |
 | Wynn Resorts | NASDAQ:WYNN | ★★★★★ | Buy Wynn Resorts Stock guide | |
 | Patterson UTI Energy | NASDAQ:PTEN | ★★★★★ | Buy Patterson UTI Energy Stock guide | |
 | J.B. Hunt Transport Services | NASDAQ:JBHT | ★★★★★ | Buy J.B. Hunt Transport Services Stock guide | |
 | SunPower | NASDAQ:SPWR | ★★★★★ | Buy SunPower Stock guide | |
 | Broadcom | NASDAQ:AVGO | ★★★★★ | Buy Broadcom Stock guide | |
 | Tractor Supply | NASDAQ:TSCO | ★★★★★ | Buy Tractor Supply Stock guide | |
 | Glu Mobile | NASDAQ:GLUU | ★★★★★ | Buy Glu Mobile Stock guide | |
 | W.W. Grainger | NYSE:GWW | ★★★★★ | Buy W.W. Grainger Stock guide | |
 | Autodesk | NASDAQ:ADSK | ★★★★★ | Buy Autodesk Stock guide | |
 | SBA Communications | NASDAQ:SBAC | ★★★★★ | Buy SBA Communications Stock guide | |
 | NetApp | NASDAQ:NTAP | ★★★★★ | Buy NetApp Stock guide | |
 | Zillow Group | NASDAQ:ZG | ★★★★★ | Buy Zillow Group Stock guide | |
 | Amgen | NASDAQ:AMGN | ★★★★★ | Buy Amgen Stock guide | |
 | Melco Resorts & Entertainment | NASDAQ:MLCO | ★★★★★ | Buy Melco Resorts & Entertainment Stock guide | |
 | Teradyne | NASDAQ:TER | ★★★★★ | Buy Teradyne Stock guide | |
 | Etsy | NASDAQ:ETSY | ★★★★★ | Buy Etsy Stock guide | |
 | TripAdvisor | NASDAQ:TRIP | ★★★★★ | Buy TripAdvisor Stock guide | |
 | WillTowers Watson Public | NASDAQ:WLTW | ★★★★★ | Buy WillTowers Watson Public Stock guide | |
 | JetBlue Airways | NASDAQ:JBLU | ★★★★★ | Buy JetBlue Airways Stock guide | |
 | Smith & Wesson Brands | NASDAQ:SWBI | ★★★★★ | Buy Smith & Wesson Brands Stock guide | |
 | AGNC Investment | NASDAQ:AGNC | ★★★★★ | Buy AGNC Investment Stock guide | |
 | Splunk | NASDAQ:SPLK | ★★★★★ | Buy Splunk Stock guide | |
 | Werner Enterprises | NASDAQ:WERN | ★★★★★ | Buy Werner Enterprises Stock guide | |
 | VaronSystems | NASDAQ:VRNS | ★★★★★ | Buy VaronSystems Stock guide | |
 | Lumentum | NASDAQ:LITE | ★★★★★ | Buy Lumentum Stock guide | |
 | Finisar | NASDAQ:FNSR | ★★★★★ | Buy Finisar Stock guide | |
 | Crocs | NASDAQ:CROX | ★★★★★ | Buy Crocs Stock guide | |
 | Cognizant Technology Solutions | NASDAQ:CTSH | ★★★★★ | Buy Cognizant Technology Solutions Stock guide | |
 | Ross Stores | NASDAQ:ROST | ★★★★★ | Buy Ross Stores Stock guide | |
 | Regeneron Pharmaceuticals | NASDAQ:REGN | ★★★★★ | Buy Regeneron Pharmaceuticals Stock guide | |
 | Lululemon Athletica | NASDAQ:LULU | ★★★★★ | Buy Lululemon Athletica Stock guide | |
 | Diamondback Energy | NASDAQ:FANG | ★★★★★ | Buy Diamondback Energy Stock guide | |
 | United Airlines | NASDAQ:UAL | ★★★★★ | Buy United Airlines Stock guide | |
 | Marvell Technology Group | NASDAQ:MRVL | ★★★★★ | Buy Marvell Technology Group Stock guide | |
 | Altair Engineering | NASDAQ:ALTR | ★★★★★ | Buy Altair Engineering Stock guide | |
 | CyberArk Software | NASDAQ:CYBR | ★★★★★ | Buy CyberArk Software Stock guide | |
 | IAC/InterActiveCorp | NASDAQ:IAC | ★★★★★ | Buy IAC/InterActiveCorp Stock guide | |
 | The Ultimate Software Group | NASDAQ:ULTI | ★★★★★ | Buy The Ultimate Software Group Stock guide | |
 | Fortinet | NASDAQ:FTNT | ★★★★★ | Buy Fortinet Stock guide | |
 | Vodafone Group | NASDAQ:VOD | ★★★★★ | Buy Vodafone Group Stock guide | |
 | Jack in the Box | NASDAQ:JACK | ★★★★★ | Buy Jack in the Box Stock guide | |
 | Microsoft | NASDAQ:MSFT | ★★★★★ | Buy Microsoft Stock guide | |
 | Endo International | NASDAQ:ENDP | ★★★★★ | Buy Endo International Stock guide | |
 | Automatic Data Processing | NASDAQ:ADP | ★★★★★ | Buy Automatic Data Processing Stock guide | |
 | Silicon Motion Technology | NASDAQ:SIMO | ★★★★★ | Buy Silicon Motion Technology Stock guide | |
 | Gilead Sciences | NASDAQ:GILD | ★★★★★ | Buy Gilead Sciences Stock guide | |
 | ClovOncology | NASDAQ:CLVS | ★★★★★ | Buy ClovOncology Stock guide | |
 | Qorvo | NASDAQ:QRVO | ★★★★★ | Buy Qorvo Stock guide | |
 | United Therapeutics | NASDAQ:UTHR | ★★★★★ | Buy United Therapeutics Stock guide | |
 | SVB Financial Group | NASDAQ:SIVB | ★★★★★ | Buy SVB Financial Group Stock guide |
English 
Svenska 
Dansk 
Nederlands 
Suomi 
Eesti 
日本語